Poland

Pfizer and BioNTech obtain positive CHMP opinion for COMIRNATY® in children aged 6 months to less than five years in the European Union

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has commercialized Array.

Pfizer and BioNTech obtain positive CHMP opinion for COMIRNATY® in children aged 6 months to less than five years in the European Union Read More »